Halaven (eribulin) is a chemotherapy that’s used to treat cancers, such as metastatic breast cancer and liposarcoma (a type of soft tissue cancer). The medication is given as an infusion through the vein (IV) on days 1 and 8 of 21-day treatment cycles. It only takes about 2 to 5 minutes to infuse. Often, Halaven (eribulin) causes low blood cell counts that can lead to fatigue and a risk for infections.
Halaven (eribulin) is a microtubule inhibitor. Microtubules are small, tube-like parts in cells that help cells grow. Halaven (eribulin) works by stopping microtubules in the body’s cells from working. When the medication blocks the microtubules in cancer cells, the cells can’t grow as easily and can die off.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Note: Side effect data are collected from studies with people who took this medication for metastatic breast cancer. Your side effect experience might differ depending on your cancer and specific treatment plan.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Yes, Halaven (eribulin) is a chemotherapy medication. Chemotherapy medications target and kill cells in the body that are rapidly growing, such as cancer cells. Halaven (eribulin) works by blocking microtubules (parts of cells that are important for cells to grow and divide). The microtubules in cancer cells are very active so that the cells can rapidly grow and divide. By interfering with how microtubules work, Halaven (eribulin) kills cancer cells and prevents them from spreading.
The Halaven (eribulin) infusion takes about 2 to 5 minutes. But on the day of your infusion appointment, you’ll probably have to do blood tests before getting treatment. For this reason, it’s a good idea to be prepared to spend a few hours at your appointment.
Talk with your provider about how long you’ll need to take Halaven (eribulin). Usually, you’ll continue taking Halaven (eribulin) until it’s no longer working to treat your cancer or until side effects like low blood counts, nerve problems, or fatigue become too troublesome.
It’s common to lose your hair during Halaven (eribulin) treatment. Some strategies you can use to prevent hair loss are to use soft brushes and avoid styles that pull hair (like braids or ponytails). If you do lose your hair, scarves, wigs, turbans, or hats can be useful options. Speak with your provider if you’re concerned about hair loss from Halaven (eribulin).
Feeling very tired is a common Halaven (eribulin) side effect. To manage fatigue, you can try to stay well hydrated, eat healthy, and schedule time for rest periodically throughout the day. It can help to keep track of when you have higher energy levels, so you can plan for more strenuous activities during those times. Let your provider know if fatigue starts to have a negative impact on your daily life.
Halaven (eribulin) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Halaven (eribulin) can lower the amount of white blood cells you have and cause neutropenia. This can raise your risk for infections that could be fatal. Usually, you’re at the most risk when your infection-fighting cells are at their lowest (a time point called nadir). In studies of people taking Halaven (eribulin), the average time to nadir was about 13 days of each treatment cycle.
Let your healthcare team know if you’re feeling ill or have signs of infection such as a fever, chills, cough, or pain or burning when urinating. Your provider will check your blood cell counts before each of your Halaven (eribulin) infusions. If you have an infection or your provider notices you have a low white blood cell count, your provider might recommend injections to help boost up your white blood cells. They might also adjust your Halaven (eribulin) dose.
Halaven (eribulin) can cause discomfort, pain, numbness, and tingling in the hands and feet. This is a nerve problem called peripheral neuropathy. In studies, some people started having these symptoms during the first 5 months of treatment, and symptoms could linger for months. Talk with your provider if you have these nerve symptoms and they’re disrupting your daily activities. They can recommend ways to help with your symptoms. They might also lower the Halaven (eribulin) dose or give you a longer break between infusions to help relieve your side effects.
Halaven (eribulin) can cause changes to your heart’s electrical activity called QT prolongation. This can affect your heart rhythm, which can sometimes be serious or life-threatening. Your risk for QT prolongation depends on your genetics, your electrolyte levels, and whether you’re taking other medications that can also affect your heart rhythm. According to a small study, this problem can occur by the time you get your second dose of Halaven (eribulin) in your treatment cycle.
Your provider will check your blood electrolyte levels before starting Halaven (eribulin) and regularly during treatment. And if you have risk factors for QT prolongation, your provider might also order an electrocardiogram (EKG) to monitor your heart’s electrical activity. Share a complete list of the medications and supplements you take with your healthcare team so they can check your risk for heart rhythm problems. Tell your provider right away if you notice new pounding or fluttering heartbeat, lightheadedness, dizziness, or chest pain during treatment.
Based on findings from animal studies and the way the medication works, Halaven (eribulin) can cause harm to unborn babies. If you’re pregnant or think you might be pregnant, talk with your provider before starting treatment with Halaven (eribulin).
Use reliable birth control while you’re taking the medication and for at least 2 weeks after the last dose if you’re able to become pregnant. And if you’re male and have a partner who can have children, you must use condoms when you have sex while you’re getting treated with Halaven (eribulin) and for 3.5 months after your last dose.
The typical dose will be based on your body surface area (BSA, measured in units of m2), which takes into account your height and weight.
Usually, the dose is 1.4 mg/m2 given as an infusion through the vein (intravenously or IV). It’s given on days 1 and 8 of each 21-day cycle of treatment (in other words, once a week for 2 weeks, then repeated after a week break).
Your dose might be lower if your liver or kidneys aren’t working well. You might also need a lower dose if you have side effects from the medication.